Discovery of potent and selective novel small molecule drugs to target estrogen receptor mutants in endocrine-resistant breast cancer

被引：0
|
作者：
Devakrishnan, Anil Kumar
Madasu, Chandrashekhar
Fuqua, Suzanne A. W.
Matzuk, Martin M.
Palaniappan, Murugesan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6576
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells
    J Y Chan
    K LaPara
    D Yee
    Oncogene, 2016, 35 : 4235 - 4243
  • [32] Exploiting novel models of endocrine-resistant breast cancer to identify new therapeutic targets
    Soosainathan, Arany
    Nikitorowicz-Buniak, Joanna
    Pancholi, Sunil
    Iravani, Marjan
    Alexander, John
    Haider, Syed
    Johnston, Stephen R.
    Dowsett, Mitchell
    Martin, Lesley A.
    Isacke, Clare M.
    CANCER RESEARCH, 2022, 82 (04)
  • [33] FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer
    Marisol Castillo-Castrejon
    Barbara Mensah Sankofi
    Stevi Johnson Murguia
    Abasi-ama Udeme
    Hoaning Howard Cen
    Yi Han Xia
    Nisha S. Thomas
    William L. Berry
    Kenneth L. Jones
    Vincent R. Richard
    Rene P. Zahedi
    Christoph H. Borchers
    James D. Johnson
    Elizabeth A. Wellberg
    Breast Cancer Research, 25
  • [34] The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
    Joanna Achinger-Kawecka
    Clare Stirzaker
    Neil Portman
    Elyssa Campbell
    Kee-Ming Chia
    Qian Du
    Geraldine Laven-Law
    Shalima S. Nair
    Aliza Yong
    Ashleigh Wilkinson
    Samuel Clifton
    Heloisa H. Milioli
    Sarah Alexandrou
    C. Elizabeth Caldon
    Jenny Song
    Amanda Khoury
    Braydon Meyer
    Wenhan Chen
    Ruth Pidsley
    Wenjia Qu
    Julia M. W. Gee
    Anthony Schmitt
    Emily S. Wong
    Theresa E. Hickey
    Elgene Lim
    Susan J. Clark
    Nature Structural & Molecular Biology, 2024, 31 : 498 - 512
  • [35] The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
    Achinger-Kawecka, Joanna
    Stirzaker, Clare
    Portman, Neil
    Campbell, Elyssa
    Chia, Kee-Ming
    Du, Qian
    Laven-Law, Geraldine
    Nair, Shalima S.
    Yong, Aliza
    Wilkinson, Ashleigh
    Clifton, Samuel
    Milioli, Heloisa H.
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Song, Jenny
    Khoury, Amanda
    Meyer, Braydon
    Chen, Wenhan
    Pidsley, Ruth
    Qu, Wenjia
    Gee, Julia M. W.
    Schmitt, Anthony
    Wong, Emily S.
    Hickey, Theresa E.
    Lim, Elgene
    Clark, Susan J.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2024, 31 (03) : 498 - 512
  • [36] ADAM22 as a Prognostic and Therapeutic Drug Target in the Treatment of Endocrine-Resistant Breast Cancer
    Bolger, Jarlath C.
    Young, Leonie S.
    HORMONES AND BREAST CANCER, 2013, 93 : 307 - 321
  • [37] Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer
    Nicholson, RI
    Hutcheson, IR
    Harper, ME
    Knowlden, JM
    Barrow, D
    McClelland, RA
    Jones, HE
    Wakeling, AE
    Gee, JMW
    ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 175 - 182
  • [38] Tamoxifen induced estrogen receptor activity in endocrine resistant breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 145 - 146
  • [39] Discovery of potent and selective small molecule NPYY5 receptor antagonists
    Islam, I
    Dhanoa, D
    Finn, J
    Du, P
    Walker, MW
    Salon, JA
    Zhang, J
    Gluchowski, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (13) : 1767 - 1769
  • [40] Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer
    Losada, J. N. Zamarbide
    Sulpice, E.
    Combe, S.
    Almeida, G. S.
    Leach, D. A.
    Choo, J.
    Protopapa, L.
    Hamilton, M. P.
    McGuire, S.
    Gidrol, X.
    Bevan, C. L.
    Fletcher, C. E.
    JOURNAL OF ENDOCRINOLOGY, 2023, 256 (03)
12345